Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Resolve Therapeutics licenses agents for autoimmune disease from University of Washington

Nov. 15, 2010

Biovista and Pfizer partner to identify new indications for Pfizer drug candidates

Nov. 11, 2010

Biocartis and bioMerieux partner to develop molecular diagnostics

Nov. 9, 2010

Covance and sanofi-aventis enter 10-year strategic collaboration

Nov. 3, 2010

Compugen licenses MAb-based oncology target to Seattle Genetics

Nov. 3, 2010

GSK and Amicus to develop Amigal for Fabry's disease

Nov. 2, 2010

Acadia enters agreement with Biovail to regain rights to pimavanserin

Nov. 2, 2010

AstraZeneca and Daiichi Sankyo announce agreement to copromote Nexium in Japan

Nov. 2, 2010

Biotie and Roche to terminate research and option agreement for SSAO inhibitors

Oct. 29, 2010

Evotec licenses EVT-201 to Jingxin Pharma

Oct. 29, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...